Who Owns Adicet Bio Stock?
NASDAQ: ACETHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 64.72%
- Held by insiders
- 1.08%
- Institutional holders
- 61
- Institutions 64.7%
- Insiders 1.1%
- Public and other 34.2%
Who owns Adicet Bio stock?
Institutional investors own about 64.7% of Adicet Bio's shares, spread across 61 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 1.08% of ACET.
The largest institutional holders are RA Capital Management, L.P. (9.96%), Orbimed Advisors LLC. (9.02%) and Franklin Resources, Inc. (6.69%). Together, the top 10 institutions control 46.6% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their ACET positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ACET
| Institution | Shares | % Held | Change |
|---|---|---|---|
| RA Capital Management, L.P. | 932.62K | 9.96% | -21.1% |
| Orbimed Advisors LLC. | 844.79K | 9.02% | -17.8% |
| Franklin Resources, Inc. | 626.57K | 6.69% | 0.0% |
| Citadel Advisors Llc | 432.74K | 4.62% | +13.3% |
| Vanguard Capital Management LLC | 343.23K | 3.67% | +2.0% |
| Adage Capital Partners GP L.L.C. | 274.38K | 2.93% | 0.0% |
| Renaissance Technologies, LLC | 265.94K | 2.84% | +14.3% |
| Stonepine Capital Management, LLC | 245.52K | 2.62% | +10.6% |
| Alyeska Investment Group, L.p. | 203.80K | 2.18% | 0.0% |
| Schonfeld Strategic Advisors Llc | 195.51K | 2.09% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ACET
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 240.95K | 2.57% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 225.19K | 2.41% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 98.91K | 1.06% |
| Bridgeway Funds, Inc.-Ultra-Small Company Fund | 85.96K | 0.92% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 42.11K | 0.45% |
| iShares Trust-iShares Micro-Cap ETF | 23.78K | 0.25% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 17.35K | 0.19% |
| Dimensional ETF Trust-Dimensional U.S. Small Cap ETF | 14.52K | 0.16% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio | 14.26K | 0.15% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 12.36K | 0.13% |
Frequently asked questions
Who is the largest shareholder of Adicet Bio?
RA Capital Management, L.P. is the largest institutional shareholder of ACET, owning 9.96% of shares outstanding (932.62K shares) as of its latest 13F filing.
What percentage of Adicet Bio is owned by institutions?
Institutions own about 64.7% of ACET shares and 65.4% of the public float.
How much of Adicet Bio do insiders own?
Insiders, such as officers and directors, own about 1.08% of ACET shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.